Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
News Focus
Saturn Oil & Gas Inc. Announces its First Development of Cardium Wells at Brazeau and Continued Successful Development (click to learn more)
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bayer ADR BAYRY

Healthcare
Bayer AG is a German-based life science company. The Company's segments are Crop Science, Pharmaceuticals and Consumer Health. The Crop Science segment focuses on seeds, improved plant traits, chemical and biological crop protection products, digital solutions and customer service for sustainable agriculture. The Pharmaceuticals segment focuses on prescription products, especially for cardiology and women's healthcare and specialty therapeutics focused on the areas of cardiology, oncology, hematology and ophthalmology, as well as gene therapy and others. The Consumer Health segment develops, produces and markets nonprescription over-the-counter medicines for self-medication. Its Consumer Health segment portfolio consists of products in dermatology, dietary supplement, analgesic, gastrointestinal, cold, allergy, sinus and flu, foot care and sun protection categories, among others.


OTCPK:BAYRY - Post by User

Bayer ADR
<< Previous
 Bullboard Posts
User Avatar Image
(86)
•••
Post by whytestockson Jan 29, 2024 7:30pm
65 Views
Post# 35851647

Roundup Cancer Verdict: Woes Continue For Bayer As It Faces

Roundup Cancer Verdict: Woes Continue For Bayer As It Faces
BREAKING NEWS: $BAYRY Roundup Cancer Verdict: Woes Continue For Bayer As It Faces $2.2B Payout | BenzingaA Pennsylvania jury has ordered&nbsp;Bayer AG&#8217;s&nbsp;(OTC:BAYRY) (OTC:BAYZF)&nbsp;Monsanto&nbsp;to pay over $2.2 billion to former Roundup us...BAYRY - Roundup Cancer Verdict: Woes Continue For Bayer As It Faces $2.2B Payout | Benzinga

<< Previous
 Bullboard Posts
Dealroom for high-potential pre-IPO opportunities